IRADIMED CORP — Form 10-Q
Filed October 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
CEO Roger Susi and CFO John Glenn certified the 10-Q for quarter ended September 30, 2026, attesting that financial statements fairly present the company's condition and results, disclosure controls are effective, and no material weaknesses or fraud involving management were identified. These are boilerplate SOX 302/906 certifications required by law for all quarterly filings.
Why this rating
Routine mandatory SOX certification exhibits; no substantive business events, financial changes, or control deficiencies disclosed.
See more from October 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.